Back to top
more

Applied Therapeutics (APLT)

(Delayed Data from NSDQ)

$9.74 USD

9.74
1,282,833

+0.09 (0.93%)

Updated Nov 7, 2024 04:00 PM ET

After-Market: $9.74 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value B Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 35% (89 out of 251)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Moderna (MRNA) in Focus: Stock Moves 6.9% Higher

by Zacks Equity Research

Moderna (MRNA) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.

Principia Biopharma (PRNB) Jumps: Stock Rises 6.8%

by Zacks Equity Research

Principia Biopharma (PRNB) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.

BeiGene (BGNE) in Focus: Stock Moves 8.7% Higher

by Zacks Equity Research

BeiGene (BGNE) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.

Is Applied Therapeutics (APLT) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Is (APLT) Outperforming Other Medical Stocks This Year?

Prothena (PRTA) Looks Good: Stock Adds 10.6% in Session

by Zacks Equity Research

Prothena (PRTA) saw a big move last session, as its shares jumped nearly 11% on the day, amid huge volumes.

89bio (ETNB) Jumps: Stock Rises 6.9%

by Zacks Equity Research

89bio (ETNB) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.

Pulmatrix (PULM) Catches Eye: Stock Jumps 6%

by Zacks Equity Research

Pulmatrix (PULM) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

Corvus Pharmaceuticals (CRVS) Catches Eye: Stock Jumps 8.4%

by Zacks Equity Research

Corvus Pharmaceuticals (CRVS) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

Seres Therapeutics (MCRB) in Focus: Stock Moves 10.8% Higher

by Zacks Equity Research

Seres Therapeutics (MCRB) saw a big move last session, as its shares jumped nearly 11% on the day, amid huge volumes.

Vaccinex (VCNX) Catches Eye: Stock Jumps 8.1%

by Zacks Equity Research

Vaccinex (VCNX) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

Magenta (MGTA) Looks Good: Stock Adds 5.2% in Session

by Zacks Equity Research

Magenta (MGTA) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

CRISPR Therapeutics (CRSP) Surges: Stock Moves 6.8% Higher

by Zacks Equity Research

CRISPR Therapeutics (CRSP) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.

Zealand (ZEAL) Surges: Stock Moves 9.1% Higher

by Zacks Equity Research

Zealand (ZEAL) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.

Avid Bioservices (CDMO) Catches Eye: Stock Jumps 5.4%

by Zacks Equity Research

Avid Bioservices (CDMO) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

Ascendis Submits BLA to FDA for TransConhGH in Pediatric GHD

by Zacks Equity Research

Ascendis Pharma (ASND) submits BLA to the FDA for TransConhGH for the treatment of pediatric growth hormone deficiency.

VBI Vaccines (VBIV) in Focus: Stock Moves 8.3% Higher

by Zacks Equity Research

VBI Vaccines (VBIV) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

AquaBounty (AQB) Catches Eye: Stock Jumps 8.9%

by Zacks Equity Research

AquaBounty (AQB) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.

BeyondSpring (BYSI) Catches Eye: Stock Jumps 10.9%

by Zacks Equity Research

BeyondSpring (BYSI) saw a big move last session, as its shares jumped nearly 11% on the day, amid huge volumes.

Precigen (PGEN) Soars: Stock Adds 9.4% in Session

by Zacks Equity Research

Precigen (PGEN) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.

Aeglea BioTherapeutics (AGLE) Catches Eye: Stock Jumps 5.1%

by Zacks Equity Research

Aeglea BioTherapeutics (AGLE) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

Why Applied Therapeutics (APLT) Stock Might be a Great Pick

by Zacks Equity Research

Applied Therapeutics (APLT) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

Selecta Biosciences (SELB) in Focus: Stock Moves 7.4% Higher

by Zacks Equity Research

Selecta Biosciences (SELB) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.

Applied Therapeutics Inc. (APLT) Moves to Strong Buy: Rationale Behind the Upgrade

by Zacks Equity Research

Applied Therapeutics Inc. (APLT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Is Applied Therapeutics (APLT) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Is (APLT) Outperforming Other Medical Stocks This Year?

Tirthankar Chakraborty headshot

New Strong Buy Stocks For June 17th

by Tirthankar Chakraborty

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today: